Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 24
Phase 41

Trial Status

Completed3
Recruiting5
Other1

Role Distribution

Principal Investigator8
Other Roles1
PI Rate89%

Activity Timeline

Clinical Trials (9)

NCT04648046Phase 1/2Active Not Recruiting
CAR-T Cells for HIV Infection
HIV Infections
PrincipalinvestigatorStart date: 2021-03-01
NCT04359186Not ApplicableRecruiting
SCOPE Analytic Treatment Interruption Protocol
HIV/AIDS
PrincipalinvestigatorStart date: 2020-10-15
NCT04362150Recruiting
Long-term Impact of Infection With Novel Coronavirus (COVID-19)
COVID
PrincipalinvestigatorStart date: 2020-04-21
NCT03606213Phase 1/2Completed
Therapeutic Vaccination in Treated HIV Disease
HIV-1-infection
PrincipalinvestigatorStart date: 2018-08-01
NCT01161199Recruiting
The Use of Leukapheresis to Support HIV Pathogenesis Studies
HIV
PrincipalinvestigatorStart date: 2010-10-26
NCT00631449Phase 4Completed
Raltegravir Intensification in HIV-infected Patients
HIV Infections
Principalinvestigator

Research Network

Collaboration Network

10 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Francisco

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Christine Katlama, MD

Groupe Hospitalier Pitie-Salpetriere

Moderately Similar
5 trials

Shared therapeutic areas:

HIV-1 InfectionHIVHIV Infections

Worked with same sponsors:

Cytheris SAMerck Sharp & Dohme LLC+2 more
Collaborated on 1 trial
Similarity Score34%

Kara Chew, MD, MS

University of California, Los Angeles

Related
1 trials

Shared therapeutic areas:

COVID-19

Worked with same sponsors:

Kara ChewNational Institute of Allergy and Infectious Diseases (NIAID)+3 more
Collaborated on 1 trial
Similarity Score14%

Dennis Hartigan-O'Connor, MD, PhD

University of California, Davis

Related
1 trials

Shared therapeutic areas:

COVID-19

Worked with same sponsors:

Kara ChewNational Institute of Allergy and Infectious Diseases (NIAID)+3 more
Collaborated on 1 trial
Similarity Score14%

François LECARDONNEL, MSc

ORVACS

Related
2 trials

Shared therapeutic areas:

HIV-1 Infection

Worked with same sponsors:

Cytheris SAMerck Sharp & Dohme LLC+2 more
Collaborated on 1 trial
Similarity Score14%

Michael J Peluso, MD

University of California, San Francisco

Related
2 trials

Shared therapeutic areas:

COVID

Worked with same sponsors:

University of California, San Francisco
Collaborated on 1 trial
Similarity Score14%

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

COVID-19COVID
Similarity Score9%

David Crowley, MD

KGK Science Inc.

Related
54 trials

Shared therapeutic areas:

COVIDCOVID-19
Similarity Score9%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

HIV
Similarity Score4%

Neha sharma, PhD

Warwick Research Services

Related
11 trials

Shared therapeutic areas:

HIV
Similarity Score4%

Xiaolong Qi, MD

LanZhou University

Related
8 trials

Shared therapeutic areas:

COVID-19
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT06810934Phase 1/2PrincipalInvestigator

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

COVID-19SARS-CoV-2 Infection
Recruiting
NCT04648046Phase 1/2PrincipalInvestigator

CAR-T Cells for HIV Infection

HIV Infections
Active Not Recruiting
NCT04359186Not ApplicablePrincipalInvestigator

SCOPE Analytic Treatment Interruption Protocol

HIV/AIDS
Recruiting
NCT04362150PrincipalInvestigator

Long-term Impact of Infection With Novel Coronavirus (COVID-19)

COVID
Recruiting
NCT03606213Phase 1/2PrincipalInvestigator

Therapeutic Vaccination in Treated HIV Disease

HIV-1-infection
Completed
NCT01161199PrincipalInvestigator

The Use of Leukapheresis to Support HIV Pathogenesis Studies

HIV
Recruiting
NCT00631449Phase 4PrincipalInvestigator

Raltegravir Intensification in HIV-infected Patients

HIV Infections
Completed
NCT01019551Phase 2StudyChair

Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients

HIV-1 Infection
Completed
NCT01202305PrincipalInvestigator

The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

HIV
Recruiting

All 9 trials loaded